BRIEF published on 08/02/2024 at 08:05, 2 years 1 month ago Information mensuelle sur les droits de vote et actions de CBo Territoria Droits De Vote Capital Social Actions AMF CBo Territoria
BRIEF published on 08/02/2024 at 08:05, 2 years 1 month ago Monthly information on the voting rights and shares of CBo Territoria Share Capital Voting Rights Actions AMF CBo Territoria
BRIEF published on 08/02/2024 at 07:35, 2 years 1 month ago MAX Automation SE Maintains Stability in a Difficult First Half of 2024 EBITDA Order Intake Economic Slowdown 2024 Financial Results MAX Automation
BRIEF published on 08/02/2024 at 07:35, 2 years 1 month ago MAX Automation SE maintient sa stabilité dans un premier semestre 2024 difficile BAIIA Prises De Commandes Résultats Financiers 2024 Ralentissement Économique Automatisation MAX
BRIEF published on 08/02/2024 at 07:35, 2 years 1 month ago SFC Energy AG: H2Genset Delivers Sustainable Energy from Green Hydrogen at Wacken Open Air 2024 Green Hydrogen SFC Energy AG Sustainable Energy H2Genset Wacken Open Air
BRIEF published on 08/02/2024 at 07:35, 2 years 1 month ago SFC Energy AG : H2Genset fournit de l'énergie durable à partir d'hydrogène vert au Wacken Open Air 2024 Hydrogène Vert L'énergie Durable SFC Energy SA Groupe Électrogène H2 Wacken En Plein Air
BRIEF published on 08/02/2024 at 07:35, 2 years 1 month ago Eurobio Scientific Completes Acquisition of EndoPredict® Genomic Test from Myriad Genetics Acquisition Eurobio Scientific EndoPredict Myriad Genetics Genomic Tests
BRIEF published on 08/02/2024 at 07:35, 2 years 1 month ago Eurobio Scientific finalise l'acquisition du test génomique EndoPredict® de Myriad Genetics Acquisition Tests Génomiques Eurobio Scientifique EndoPredict Une Myriade De Génétique
BRIEF published on 08/02/2024 at 07:05, 2 years 1 month ago Mobimo accroît son bénéfice au premier semestre 2024 Immobilier Mobimo Bénéfice Semestriel Développements Revalorisation
BRIEF published on 08/02/2024 at 07:05, 2 years 1 month ago Mobimo increases its profit in the first half of 2024 Real Estate Mobimo Revaluation Half-year Profit Developments
Published on 09/11/2026 at 17:00, 36 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 36 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 2 hours 11 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 2 hours 36 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 3 hours 6 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 16:30, 1 hour 6 minutes ago Belt and Road Summit in Hong Kong welcomes over 6,200 global leaders to explore new business opportunities
Published on 09/11/2026 at 16:00, 1 hour 36 minutes ago Deutsche Postbank Funding Trust III published semi-annual report
Published on 09/11/2026 at 16:00, 1 hour 36 minutes ago Form 8.3 - IPConcept (Luxemburg) S.A.: SONNTAG Premium
Published on 09/11/2026 at 15:29, 2 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/11/2026 at 15:24, 2 hours 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC
Published on 09/11/2026 at 07:00, 10 hours 36 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 10 hours 36 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 10 hours 36 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 10 hours 36 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 22 hours 6 minutes ago Availability of the 2026 Interim Financial Report
